| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA708719 | Functional | In vivo antitumor activity against the L1210 leukemia cell line in mouse species B6D2F1 after peroral administration (inoculum cells-10E5,iv) at the dose of 100 mg/kg on 7th day | Mus musculus | 4 | ALA1125112 | organism-based format | Scientific Literature | |
| 2. | ALA708722 | Functional | In vivo antitumor activity against the L1210 leukemia cell line in mouse species B6D2F1 after peroral administration (inoculum cells-10E5,iv) at the dose of 200 mg/kg on 7th day | Mus musculus | 3 | ALA1125112 | organism-based format | Scientific Literature | |
| 3. | ALA708882 | Functional | In vivo antitumor activity against the L1210 leukemia cell line in mouse species B6D2F1 after peroral administration (inoculum cells-10E5,iv) at the dose of 50 mg/kg on 7th day | Mus musculus | 2 | ALA1125112 | organism-based format | Scientific Literature | |
| 4. | ALA707282 | Functional | In vivo antitumor activity against the L1210 leukemia cell line in mouse species B6D2F1 after peroral administration (inoculum cells-10E5,iv) at the dose of 100 mg/kg | Mus musculus | 4 | ALA1125112 | organism-based format | Scientific Literature | |
| 5. | ALA706346 | Functional | In vivo antitumor activity against the L1210 leukemia cell line in mouse species B6D2F1 after peroral administration (inoculum cells-10E5,iv) at the dose of 200 mg/kg | Mus musculus | 4 | ALA1125112 | organism-based format | Scientific Literature | |
| 6. | ALA706349 | Functional | In vivo antitumor activity against the L1210 leukemia cell line in mouse species B6D2F1 after peroral administration (inoculum cells-10E5,iv) at the dose of 50 mg/kg | Mus musculus | 2 | ALA1125112 | organism-based format | Scientific Literature | |
| 7. | ALA812045 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 160 mg/kg on 5th day | Mus musculus | 9 | ALA1125112 | organism-based format | Scientific Literature | |
| 8. | ALA812047 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 20 mg/kg on 5th day | Mus musculus | 12 | ALA1125112 | organism-based format | Scientific Literature | |
| 9. | ALA812049 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 320 mg/kg on 5th day | Mus musculus | 7 | ALA1125112 | organism-based format | Scientific Literature | |
| 10. | ALA812050 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 40 mg/kg | Mus musculus | 1 | ALA1125112 | organism-based format | Scientific Literature | |
| 11. | ALA812724 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 80 mg/kg on 5th day | Mus musculus | 11 | ALA1125112 | organism-based format | Scientific Literature | |
| 12. | ALA809234 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 160 mg/kg | Mus musculus | 9 | ALA1125112 | organism-based format | Scientific Literature | |
| 13. | ALA809236 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 20 mg/kg | Mus musculus | 13 | ALA1125112 | organism-based format | Scientific Literature | |
| 14. | ALA809237 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 320 mg/kg | Mus musculus | 8 | ALA1125112 | organism-based format | Scientific Literature | |
| 15. | ALA809239 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 40 mg/kg on 5th day | Mus musculus | 1 | ALA1125112 | organism-based format | Scientific Literature | |
| 16. | ALA809242 | Functional | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 80 mg/kg | Mus musculus | 13 | ALA1125112 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!